Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

PPL Therapeutics reports positive phase I results for AAT

June 3, 1997

Antiallergic/antiasthmatic agents from Sumitomo Metal

June 2, 1997

T Cell Sciences completes patient enrollment for reperfusion injury trial

June 2, 1997

Positive preclinical results for Inflazyme's Apanol

June 2, 1997

U.K. introduction for Nasonex

May 29, 1997

Selective M3 antagonists from Banyu

May 29, 1997

FLAP inhibitor from Bayer inhibits allergen-induced bronchoconstriction in atopic asthmatics

May 28, 1997

Chiroscience discloses cytokine inhibitors

May 28, 1997

Leukotriene antagonists from Pfizer

May 28, 1997

Opioid antagonists/agonists described by Toray

May 27, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...